5-Chloro-2-nitrobenzoic acidCAS# 2516-95-2 |
Quality Control & MSDS
Number of papers citing our products
Chemical structure
3D structure
Cas No. | 2516-95-2 | SDF | Download SDF |
PubChem ID | 17286 | Appearance | Powder |
Formula | C7H4ClNO4 | M.Wt | 201.6 |
Type of Compound | N/A | Storage | Desiccate at -20°C |
Solubility | Soluble in Chloroform,Dichloromethane,Ethyl Acetate,DMSO,Acetone,etc. | ||
SMILES | C1=CC(=C(C=C1Cl)C(=O)O)[N+](=O)[O-] | ||
Standard InChIKey | ZKUYSJHXBFFGPU-UHFFFAOYSA-N | ||
Standard InChI | InChI=1S/C7H4ClNO4/c8-4-1-2-6(9(12)13)5(3-4)7(10)11/h1-3H,(H,10,11) | ||
General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months. We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months. Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it. |
||
About Packaging | 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial. 2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial. 3. Try to avoid loss or contamination during the experiment. |
||
Shipping Condition | Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request. |
5-Chloro-2-nitrobenzoic acid Dilution Calculator
5-Chloro-2-nitrobenzoic acid Molarity Calculator
1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
1 mM | 4.9603 mL | 24.8016 mL | 49.6032 mL | 99.2063 mL | 124.0079 mL |
5 mM | 0.9921 mL | 4.9603 mL | 9.9206 mL | 19.8413 mL | 24.8016 mL |
10 mM | 0.496 mL | 2.4802 mL | 4.9603 mL | 9.9206 mL | 12.4008 mL |
50 mM | 0.0992 mL | 0.496 mL | 0.9921 mL | 1.9841 mL | 2.4802 mL |
100 mM | 0.0496 mL | 0.248 mL | 0.496 mL | 0.9921 mL | 1.2401 mL |
* Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations. |
Calcutta University
University of Minnesota
University of Maryland School of Medicine
University of Illinois at Chicago
The Ohio State University
University of Zurich
Harvard University
Colorado State University
Auburn University
Yale University
Worcester Polytechnic Institute
Washington State University
Stanford University
University of Leipzig
Universidade da Beira Interior
The Institute of Cancer Research
Heidelberg University
University of Amsterdam
University of Auckland
TsingHua University
The University of Michigan
Miami University
DRURY University
Jilin University
Fudan University
Wuhan University
Sun Yat-sen University
Universite de Paris
Deemed University
Auckland University
The University of Tokyo
Korea University
- Tesaglitazar
Catalog No.:BCC7828
CAS No.:251565-85-2
- M344
Catalog No.:BCC2162
CAS No.:251456-60-7
- SU 16f
Catalog No.:BCC7639
CAS No.:251356-45-3
- Urotensin II (human)
Catalog No.:BCC5796
CAS No.:251293-28-4
- Crebanine
Catalog No.:BCN5117
CAS No.:25127-29-1
- FRATide
Catalog No.:BCC5821
CAS No.:251087-38-4
- Antazoline HCl
Catalog No.:BCC4627
CAS No.:2508-72-7
- Salvisyrianone
Catalog No.:BCN4821
CAS No.:250691-57-7
- NNC 63-0532
Catalog No.:BCC7177
CAS No.:250685-44-0
- Pedunsaponin A
Catalog No.:BCN8192
CAS No.:250613-27-5
- Cyclo(RGDyK)
Catalog No.:BCC6512
CAS No.:250612-42-1
- (±)-Acetylcarnitine chloride
Catalog No.:BCC6617
CAS No.:2504-11-2
- Acevaltrate
Catalog No.:BCN7127
CAS No.:25161-41-5
- Loline
Catalog No.:BCN2003
CAS No.:25161-91-5
- Isohomoarbutin
Catalog No.:BCN7612
CAS No.:25162-30-5
- Dynamin inhibitory peptide
Catalog No.:BCC1034
CAS No.:251634-21-6
- AM 1172
Catalog No.:BCC7675
CAS No.:251908-92-6
- SLV 320
Catalog No.:BCC7656
CAS No.:251945-92-3
- A 205804
Catalog No.:BCC3944
CAS No.:251992-66-2
- AZD7545
Catalog No.:BCC4294
CAS No.:252017-04-2
- Fmoc-D-Threoninol
Catalog No.:BCC2702
CAS No.:252049-02-8
- Fmoc-Lys(Me2)-OH
Catalog No.:BCC2567
CAS No.:252049-10-8
- Tertiapin-Q
Catalog No.:BCC5740
CAS No.:252198-49-5
- 1-Cinnamoylpyrrole
Catalog No.:BCN4006
CAS No.:252248-89-8
Hydrogen-bonded structures of the isomeric compounds of quinoline with 2-chloro-5-nitrobenzoic acid, 3-chloro-2-nitrobenzoic acid, 4-chloro-2-nitrobenzoic acid and 5-chloro-2-nitrobenzoic acid.[Pubmed:19805889]
Acta Crystallogr C. 2009 Oct;65(Pt 10):o534-8.
The structures of four isomeric compounds, all C7H4ClNO4.C9H7N, of quinoline with chloro- and nitro-substituted benzoic acid, namely, 2-chloro-5-nitrobenzoic acid-quinoline (1/1), (I), 3-chloro-2-nitrobenzoic acid-quinoline (1/1), (II), 4-chloro-2-nitrobenzoic acid-quinoline (1/1), (III), and 5-Chloro-2-nitrobenzoic acid-quinoline (1/1), (IV), have been determined at 185 K. In each compound, a short hydrogen bond is observed between the pyridine N atom and a carboxyl O atom. The N...O distances are 2.6476 (13), 2.5610 (13), 2.5569 (12) and 2.5429 (12) A for (I), (II), (III) and (IV), respectively. Although in (I) the H atom in the hydrogen bond is located at the O site, in (II), (III) and (IV) the H atom is disordered in the hydrogen bond over two positions with (N site):(O site) occupancies of 0.39 (3):0.61 (3), 0.47 (3):0.53 (3) and 0.65 (3):0.35 (3), respectively.